Trial · NCT07895368
Intravenous Lidocaine Versus Erector Spinae Plane Block After Lumbar Arthrodesis (LIBERA)
NCT07895368, Not applicable, Not yet recruiting, GCS Ramsay Santé pour l'Enseignement et la Recherche
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Intravenous Lidocaine Versus Erector Spinae Plane Block After Lumbar Arthrodesis (LIBERA). Trials, record NCT07895368. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07895368
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Intravenous Lidocaine Versus Erector Spinae Plane Block After Lumbar Arthrodesis (LIBERA)
- NCT number
- NCT07895368
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 90 participants, estimated
- Lead sponsor
- GCS Ramsay Santé pour l'Enseignement et la Recherche
- Conditions
- Single-level Lumbar Arthrodesis
- Interventions
- Single-level posterior lumbar arthrodesis
- First posted
- 2026-10-26
- Last updated
- 2026-10-26
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Total morphine consumption within 48 hours after surgery, expressed in milligrams (mg), calculated as the cumulative consumption of intravenous (IV) morphine administered in the PACU and oral morphine converted to IV morphine equivalents. | From the end of surgery up to 48 hours postoperatively | Cumulative dose of intravenous morphine administered in the post-anesthesia care unit and oral oxycodone administered after discharge from the post-anesthesia care unit, converted into intravenous morphine equivalents. Unit in milligrams (mg). |
| Secondary | Postoperative pain intensity assessed using the 0-10 Numerical Rating Scale (0-10 NRS) | At PACU discharge and at 12, 24, and 48 hours postoperatively. | Postoperative pain intensity, assessed using an 11-point Numerical Rating Scale (NRS) ranging from 0 (no pain) to 10 (worst imaginable pain). Pain scores will be recorded by nursing staff blinded to treatment allocation following routine clinical practice. Pain intensity will be compared between the treatment groups. |
| Secondary | Quality of postoperative recovery assessed using the Quality of Recovery-15 (QoR-15) questionnaire | 72 hours postoperatively. | Quality of postoperative recovery assessed using the Quality of Recovery-15 (QoR-15) questionnaire. The QoR-15 evaluates five dimensions of postoperative recovery: pain, physical comfort, physical independence, psychological support, and emotional state. The questionnaire consists of 15 items, each scored on an 11-point scale (rated from 0 to 10), with higher scores indicating better recovery. The total QoR-15 score is calculated by summing the scores of all items. Total QoR-15 score (range: 0-150, with higher scores indicating better postoperative recovery). |
| Secondary | Time to first morphine administration | From the end of surgery until the first morphine administration, up to 48 hours postoperatively. | Time elapsed between arrival in the post-anesthesia care unit (PACU) and administration of the first dose of morphine for postoperative pain management. Time in minutes (min).Participants who do not receive morphine within 48 hours will be censored at 48 hours. |
| Secondary | Morphine consumption during stay in the post-anesthesia care unit (PACU) | From PACU admission until PACU discharge. | Total amount of morphine administered during the stay in the post-anesthesia care unit (PACU) for postoperative pain management, expressed in milligrams (mg). Medication administration records. |
| Secondary | Duration of stay in the post-anesthesia care unit (PACU) | From PACU admission until PACU discharge. | Time elapsed between PACU admission and PACU discharge in Minutes (min). |
| Secondary | Total duration of hospital stay | From hospital admission until hospital discharge.(expected within approximately 3 days after surgery) | Time elapsed between hospital admission for surgery and hospital discharge in Days |
| Secondary | Incidence of treatment-related adverse events | From the start of study procedure to 72 hours after surgery. | Incidence of adverse events (AEs) and serious adverse events (SAEs) for which a causal relationship with the study analgesic treatment cannot be excluded, as assessed by the investigator. Adverse event collection and clinical assessment recorded in the electronic case report form (eCRF), categorized by seriousness and severity. Number and percentage of participants with at least one treatment-related adverse event. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07895368
GET https://conductscience.org/api/trials/v1/NCT07895368/registered